๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 158 Harbin 7 Wuhan 6 Zhengzhou 6 Chongqing 5
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158 Clear sponsor filter
Site location
Beijing158 Harbin7 Wuhan6 Zhengzhou6 Chongqing5
All 34 locations
Target enrolment
to

Trials with a site in Beijing

158 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
The Effect of Different Delivery Positions on Pelvic Floor Function.
NCT07081321Stress Urinary Incontinence (SUI)
Peking University People's Hospital
Not applicable
1,992
Beijing
2026-09-20
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
NCT07796516Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis
DrugTelitacicept
Peking University People's Hospital
Phase 2
420
Hefei, Beijing, Chongqing, Quanzhou, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-09-01
Not yet open
Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Lobectomy
NCT07721558Atelectasis, Postoperative Pulmonary Complications
Peking University People's Hospital
Not applicable
100
Beijing
2026-09-01
Not yet open
Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder
NCT07809724Neuromyelitis Optica Spectrum Disorder (NMOSD)
DrugInterleukin-2
Peking University People's Hospital
Phase 2
60
Beijing
2026-08-30
Not yet open
Real-World Efficacy and Safety of Tenapanor Plus Phosphate Binders in Hemodialysis Patients With Hyperphosphatemia
NCT07776119CKD 5D, Hemodialysis, Hyperphosphatemia Undergoing Hemodialysis
Peking University People's Hospital
Observational
200
Beijing
2026-08-20
Recruiting
Comprehensive Assessment System for Fallopian Tube Function and Clinical Study on Individualized Treatment Strategies
NCT07808229Multidimensional Tubal Function Assessment and Individualized Treatment Strategies for Tubal Factor Infertility
Peking University People's Hospital
Not applicable
240
Beijing
2026-08-01
Not yet open
Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer
NCT07656766Advanced Colorectal Cancer
DrugSintilimab
Peking University People's Hospital
Phase 2
32
Beijing
2026-07-15
Recruiting
Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT
NCT07677306Myelodysplastic Syndromes
Peking University People's Hospital
Phase 2
120
Beijing
2026-07-15
Recruiting
Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer
NCT07600164HER2 + Breast Cancer, Advanced Breast Cancer
DrugsPyrotinib·Trastuzumab Rezetecan
Peking University People's Hospital
Phase 4
500
Beijing
2026-07-06
Recruiting
The Effect of Exercise-Induced Irisin on Brain Function and Postoperative Delirium in Older Adults
NCT07424170Post Operative Delirium
Peking University People's Hospital
Observational
140
Beijing
2026-07-01
Not yet open
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
NCT07714070Endometrial Neoplasms, Endometrial Cancer, Atypical Endometrial Hyperplasia, Progestin Resistance
DrugsOrlistat·Progestin
Peking University People's Hospital
Phase 2
48
Beijing
2026-07
Recruiting
Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia
NCT07629947Severe Aplastic Anemia (SAA)
Peking University People's Hospital
Not applicable
180
Beijing
2026-06-15
Not yet open
Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma
NCT07620431Ewing Sarcoma, Bone Neoplasms
Peking University People's Hospital
Observational
55
Beijing
2026-06-01
Not yet open
Deep Learning Time-Series Prediction of Long-Term Growth Patterns of Pulmonary Ground-Glass Nodules Using Serial CT
NCT07647692Pulmonary Nodules, Lung Neoplasms, Adenocarcinoma of Lung
Peking University People's Hospital
Observational
4,750
Beijing
2026-06-01
Not yet open
Atorvastatin Combined With NAC Plus Romiplostim for Management of ITP
NCT07662525Immune Thrombocytopenic Purpura
Peking University People's Hospital
Not applicable
50
Beijing
2026-06-01
Recruiting
A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
NCT07586735Severe Aplastic Anemia, Aplastic Anaemia, Hematopoietic Cell Transplant
Peking University People's Hospital
Observational
64
Beijing
2026-06
Not yet open
ATRA for Management of Primary ITP
NCT07597395Immune Thrombocytopenia
Peking University People's Hospital
Phase 3
192
Beijing
2026-05-30
Recruiting
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
NCT07574346Malignancies
Peking University People's Hospital
Phase EARLY_PHASE1
18
Beijing
2026-05-29
Recruiting
IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
NCT07617740REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Peking University People's Hospital
Phase EARLY_PHASE1
18
Beijing
2026-05-25
Recruiting
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML
NCT07617285AML, Refractory/Relapse Acute Myeloid Leukemia
Peking University People's Hospital
Phase 1
27
Beijing
2026-05-07
Not yet open
Clinical Application of Vagus Nerve Stimulation Combined With Immunoregulatory T Cells in Alleviating Aromatase Inhibitor-Induced Pain
NCT07593365Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Breast Cancer, Pain Alleviation
Peking University People's Hospital
Not applicable
216
Beijing
2026-05-06
Recruiting
CDK4/6 Inhibitors Combined With Endocrine Therapy for Neoadjuvant Treatment
NCT07366112Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
Peking University People's Hospital
Phase 2
158
Beijing
2026-04-20
By invitation
Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative Surgery for Submucosal Tumor at the Gastroesophageal Junction
NCT07550582Submucosal Tumor of Gastrointestinal Tract, Gastrointestinal Stromal Tumor (GIST)
Peking University People's Hospital
Phase 2
40
Beijing
2026-04-01
Not yet open
A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer
NCT07294339Acupuncture Treatment, Hormone Receptor-Positive Breast Cancer, Hot Flashes
Peking University People's Hospital
Not applicable
60
Beijing
2026-04-01
Not yet open
Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients
NCT07559032Invasive Fungal Disease
DrugAmphotericin B
Peking University People's Hospital
Not applicable
15
Beijing
2026-04
Recruiting
Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML
NCT07500441Acute Myeloid Leukemia (AML)
Peking University People's Hospital
Observational
100
Beijing
2026-03-20
Recruiting
Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
NCT07487883Non-Small Cell Lung Cancer, Malignant Neoplasm, Pulmonary Nodules, PET/CT
Peking University People's Hospital
Observational
80
Beijing
2026-03-18
Recruiting
Baricitinib for Post-HSCT Persistent Thrombocytopenia
NCT07535645Persistent Thrombocytopenia, Allogeneic Hematopoietic Stem Cell Transplantation
DrugBaricitinib
Peking University People's Hospital
Phase 1/2
28
Beijing
2026-03-09
Recruiting
Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma
NCT07479732Osteosarcoma, Osteosarcoma Metastatic
DrugLiposomal Irinotecan
Peking University People's Hospital
Phase 1/2
56
Beijing
2026-03-05
Recruiting
Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors
NCT07400263Epithelial Tumors, Malignant
Peking University People's Hospital
Not applicable
30
Beijing
2026-03-04
Recruiting
A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients
NCT07238894Ablation, Breast Cancer
Peking University People's Hospital
Not applicable
200
Beijing
2026-03-03
Not yet open
IFN-ฮฑ in Relapse Prevention.
NCT07449286Acute Myeloid Leukemia, Myelodysplastic Syndromes
DrugIFN-ฮฑ
Peking University People's Hospital
Phase 2
100
Beijing
2026-03-01
Recruiting
Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia
NCT07588594Chronic Myelomonocytic Leukemia (CMML)
Peking University People's Hospital
Not applicable
31
Beijing
2026-02-13
Recruiting
Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis
NCT07335887AL Amyloidosis (AL), t(11;14) Positive
Peking University People's Hospital
Phase 2
39
Beijing, Xi'an
2026-02-10
Active, closed
Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning
NCT07509632Rectal Cancers, Pathological Complete Response, Neoadjuvant Chemoradiotherapy, Machine Learning
Peking University People's Hospital
Observational
320
Beijing
2026-02-04
Recruiting
Fucoidan in the Treatment of Active Rheumatoid Arthritis
NCT07045896Arthritis, Rheumatoid
Peking University People's Hospital
Not applicable
40
Beijing
2026-01-10
Active, closed
Fecal Microbiota Transplantation for Steroid-resistant or Relapsed Immune Thrombocytopenia
NCT07733037Immune Thrombocytopenia (ITP)
DrugFecal Microbiota Transplantation
Peking University People's Hospital
Phase 2
42
Beijing
2026-01-10
Recruiting
An Open and Dose-escalation Early Clinical Study of CD19 and CD20 CAR-T Cell Therapy for Relapsed or Refractory Aggressive B-cell Lymphoma
NCT07344818R/R Aggressive B-cell Lymphoma
Peking University People's Hospital
Phase EARLY_PHASE1
18
Beijing
2026-01-07
Recruiting
Immunomodulatory Therapy and Predictors of Clinical Cure in Chronic Hepatitis B
NCT07328711Chronic Hepaititis B
Peking University People's Hospital
Phase EARLY_PHASE1
132
Beijing
2026-01-01
Not yet open
Critical Illness After Hematopoietic Cell Transplantation
NCT07328724Critical Illness, Ventilated Patients, Hematopoetic Stem Cell Transplantation, Transplant Complication
Peking University People's Hospital
Observational
4,000
Beijing, Chongqing, Hangzhou, Harbin, Tianjin, Wuhan
2026-01-01
Recruiting
Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation
NCT07349498Hematopoietic Stem Cell Transplantation, Transplant Complication, Cardiovascular Events
Peking University People's Hospital
Observational
10,000
Beijing, Chongqing, Guangzhou, Shenzhen, Harbin, Zhengzhou, Wuhan, Xi'an
2026-01-01
Recruiting
Ablation Compare With Surgery for Early Breast Cancer
NCT07484087Breast Cancer, Early Stage, Hormone Receptor Positive, Ablation
Peking University People's Hospital
Not applicable
264
Beijing
2026-01-01
Recruiting
Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
NCT06946654Elderly, Geriatric Assessment, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital
Observational
176
Beijing
2026-01-01
Recruiting
Conditioning Regimen in Elderly AML Patients Receiving Haplo-HSCT.
NCT06946602AML, Elderly
Peking University People's Hospital
Not applicable
307
Beijing
2026-01-01
Recruiting
Clinical Validation of a Pre-trained and Fine-tuned Model for Analyzing Time-Series Electronic Health Records in Critical Care
NCT07795450Critical Care Medicine, Mortality Prediction
Peking University People's Hospital
Observational
4,800
Beijing
2026-01-01
Not yet open
ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab
NCT07320326TCE-RRMM
DrugElranatamab
Peking University People's Hospital
Observational
159
Beijing
2025-12-30
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors
NCT07586826Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gynecologic Cancers, Ovarian Cancer
DrugsAll-trans retinoic acid·Romiplostim N01
Peking University People's Hospital
Phase 2
220
Beijing
2025-12-22
Recruiting
Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors
NCT07586813Persistent Isolated Chemotherapy-Induced Thrombocytopenia, Chemotherapy-Induced Thrombocytopenia, Gastrointestinal Neoplasms, Pancreatic Cancer
DrugsAll-trans retinoic acid·Romiplostim N01
Peking University People's Hospital
Phase 2
220
Beijing
2025-12-22
Active, closed
the Exploration of MTAP Deletion in Osteosarcoma by Immunohistochemistry
NCT07593573Osteosarcoma, MTAP Deletion, Immunohistochemistry
Peking University People's Hospital
Observational
100
Beijing
2025-12-15
Recruiting
CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
NCT07441291B ALL, Allogenetic Hematopoietic Stem Cell Transplantation, MRD-positive
DrugCar-T
Peking University People's Hospital
Phase 3
70
Beijing
2025-11-30
Recruiting
A Prediction Model in Pregnant Women With Aplastic Anemia
NCT07101770Aplastic Anemia, Pregnancy, Prediction Model
Peking University People's Hospital
Observational
300
Beijing
2025-11-27
Recruiting
Real-world Study of Aflibercept 8 mg in nAMD
NCT07640997Neovascular Age-Related Macular Degeneration (nAMD)
DrugAflibercept
Peking University People's Hospital
Observational
300
Beijing, Fuzhou, Shenzhen, Zunyi, Harbin, Nanyang, Wuhan, Hohhot
2025-11-11
Not yet open
An Exploratory Study of Golidocitinib in Adult Patients With ITP
NCT07196163Immune Thrombocytopenia (ITP)
DrugGolidocitinib
Peking University People's Hospital
Phase 1/2
138
Beijing
2025-10-30
Recruiting
Light and Anesthesia
NCT07517484Light, Anesthesia, Sedation
Peking University People's Hospital
Not applicable
66
Beijing
2025-10-03
Recruiting
Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma
NCT07725783Ewing Sarcoma
Peking University People's Hospital
Observational
100
Beijing
2025-09-01
Recruiting
The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2)
NCT07065968Immune Thrombocytopenia (ITP)
DrugsTeriflunomide·Dexamethasone
Peking University People's Hospital
Phase 2
132
Beijing
2025-08-19
Recruiting
To Observe the CD7-targeted CAR-T Therapy in the Treatment of r/r PTCL
NCT07143929CD7 Positive R/R PTCL
DrugCar-T
Peking University People's Hospital
Phase 1
18
Beijing
2025-08-18
Recruiting
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
NCT07280494CD7+ T-ALL/LBL
Peking University People's Hospital
Phase 1
18
Beijing
2025-08-18
Recruiting
ctDNA-Guided De-Escalation of Adjuvant Chemotherapy With Dalpiciclib in HR-Positive/HER2-Negative Breast Cancer
NCT06970912Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, Early-Stage Breast Cancer, HER2-negative Breast Cancer
DrugDalpiciclib
Peking University People's Hospital
Phase 2
393
Beijing
2025-08-01
Not yet open
The Combination of Upadacitinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
NCT07064889Immune Thrombocytopenia
DrugsUpadacitinib·Dexamethasone
Peking University People's Hospital
Phase 2
132
Beijing
2025-07-30
Recruiting
Real-world Immuno-therapy in Chinese Newly Diagnosed Multiple Myeloma Patients
NCT07296627Newly Diagnosed Multiple Myeloma (NDMM)
Peking University People's Hospital
Observational
500
Beijing
2025-07-16
Not yet open
Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy
NCT06942377Endometrial Cancer
Peking University People's Hospital
Phase 2
140
Beijing
2025-07-15
By invitation
Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?
NCT07494006Lung Cancer, OLV, Hypoxemia During Surgery
Peking University People's Hospital
Observational
44
Beijing
2025-07-15
Not yet open
Longitudinal Observational Study on Immune Thrombocytopenia
NCT07068425Immune Thrombocytopenia (ITP)
Peking University People's Hospital
Observational
2,000
Beijing
2025-07-10
Not yet open
Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP
NCT07057778Immune Thrombocytopenia (ITP)
DrugsIguratimod·Rituximab
Peking University People's Hospital
Phase 2
120
Beijing
2025-07-01
Recruiting
Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
NCT07359040Non-Small Cell Lung Cancer, Neoadjuvant Therapy, PD-1 Inhibitors, Immunotherapy
DrugsNivolumab·Bevacizumab
Peking University People's Hospital
Observational
80
Beijing
2025-07-01
Recruiting
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
NCT07111260End Stage Renal Disease on Dialysis
Peking University People's Hospital
Not applicable
34
Beijing
2025-07-01
Not yet open
Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV
NCT06986018Idiopathic Inflammatory Myopathies, ANCA-Associated Vasculitis
DrugRD06
Peking University People's Hospital
Phase EARLY_PHASE1
12
Beijing
2025-06-14
Recruiting
FAP-targeted PET/NIR in Lung Malignant Tumors
NCT07498933Non-Small Cell Lung Cancer, PET/CT, Neoadjuvant Therapy
Peking University People's Hospital
Observational
200
Beijing
2025-06-03
Recruiting
Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
NCT07537738Acute Myeloid Leukemia (AML), MLL Rearrangement
Peking University People's Hospital
Observational
210
Beijing
2025-06-01
Not yet open
Comparison of ultraSound, Abbreviated MRI witH and Without HBP aS mOdalities for HCC suRveillance in patienTs With High Risk
NCT07010588Hepatocellular Carcinoma (HCC), Magnetic Resonance Imaging (MRI), Randomized Controlled Trial
Peking University People's Hospital
Not applicable
1,389
Beijing, Chongqing, Handan, Harbin, Wuhan, Changchun, Jinan, Qingdao
2025-06
By invitation
Mass Spectrometry-based Immune Profiling in Autoimmune Diseases
NCT07188285Systemic Lupus Erthematosus, Sjogren's Syndrome, Inflammatory Myopathies, Systemic Sclerosis (SSc)
Peking University People's Hospital
Observational
500
Beijing
2025-05-25
Recruiting
Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT
NCT06984536Myelodysplastic Syndrome, Acute Leukemia
Peking University People's Hospital
Phase 2
40
Beijing
2025-05-21
Not yet open
Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia
NCT06971913SLE (Systemic Lupus), CMV
DrugsGanciclovir·Interleukin-2
Peking University People's Hospital
Phase 2
100
Beijing
2025-05-20
Recruiting
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
NCT07291921Lung Neoplasms, Neoadjuvant Therapy, Immunotherapy, Minimal Residual Disease
Peking University People's Hospital
Observational
100
Beijing
2025-05-08
Recruiting
Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia
NCT06869265Acute Myeloid Leukemia (AML), High Risk Acute Myeloid Leukemia(AML), Relapsed/Refractory Acute Myeloid Leukemia (AML)
Peking University People's Hospital
Phase 2
56
Beijing
2025-05-01
Recruiting
Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease
NCT07653711End Stage Renal Disease on Dialysis
Peking University People's Hospital
Not applicable
30
Beijing
2025-04-21
Active, closed
Effects of HIPEC on Postoperative Bowel Motility and Complications
NCT07353177HIPEC, Gastro Intestinal Cancer, Adhesion Prevention, Bowel Functions
Peking University People's Hospital
Observational
193
Beijing
2025-04-20
Active, closed
Efficacy and Safety of Laparoscopic Lateral Suspension and Transvaginal Sacrospinous Ligament Fixation in Patients With Pelvic Organ Prolapse
NCT06903988Pelvic Organ Prolapse (POP)
Peking University People's Hospital
Not applicable
86
Beijing
2025-04-05
Not yet open
Application-Assisted Weight Management in Endometrial Cancer Fertility Preservation
NCT06901778Endometrial Cancer, Mobile Applications, Weight Management
Peking University People's Hospital
Not applicable
106
Beijing
2025-03-31
Recruiting
Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis
NCT06699394AL Amyloidosis
Peking University People's Hospital
Not applicable
20
Beijing
2025-03-29
Active, closed
Autologous Fecal Microbiota Transplantation for Anal Function Recovery After Ileostomy Reversal in Rectal Cancer
NCT07711509Rectal Cancer, Low Anterior Resection Syndrome, Fecal Incontinence, Diversion Colitis
Peking University People's Hospital
Not applicable
35
Beijing
2025-03-25
Recruiting
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
NCT06930807Non-small Cell Lung Cancer, Minimal Residual Disease, Adaptive Treatment
Peking University People's Hospital
Not applicable
1,000
Beijing
2025-03-25
Recruiting
Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07569055Invasive Fungal Disease, Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Peking University People's Hospital
Observational
6,000
Beijing
2025-03-15
Not yet open
Therapeutic Effect of Upadacitinib in Primary Sjรถgren's Syndrome
NCT06862284Primary Sjรถgren's Syndrome (pSS)
Peking University People's Hospital
Phase 2
30
Beijing
2025-03-10
Recruiting
Kahook Dual Blade Goniotomy in Chronic Primary Angle-Closure Glaucoma
NCT07517302Primary Angle-closure Glaucoma
Peking University People's Hospital
Not applicable
68
Beijing
2025-03-01
Active, closed
Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma
NCT06924424Multiple Myeloma, Neoplasms
Peking University People's Hospital
Not applicable
105
Beijing, Zhengzhou
2025-03-01
Recruiting
KPD Consolidation After ASCT in NDMM Patients
NCT06879379Multiple Myeloma, Newly Diagnosed
Peking University People's Hospital
Phase 2/3
202
Beijing, Shanghai
2025-03
Recruiting
Nanobody-Based Anti-CD5 CAR-T for Relapsed/Refractory T-ALL/NHL
NCT06874946Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T - Cell Lymphoma, PTCL
Peking University People's Hospital
Phase 1/2
30
Beijing
2025-02-14
Recruiting
Comparative Study on the Effect of Diet Interventions on Weight Loss in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
NCT07318727Endometrium Cancer
Peking University People's Hospital
Not applicable
81
Beijing
2025-01-10
By invitation
The Application of Novel Identified CD8 Regulatory Precursors in Inducing Immune Tolerance After Allo-HSCT
NCT06864598Graft-versus-host Disease (GVHD)
Peking University People's Hospital
Observational
100
Beijing
2025-01-09
Recruiting
Endoscopic and Robotic NSM with Immediate Prosthesis Breast Reconstruction
NCT06748677Nipple-sparing Mastectomy, Immediate Prosthesis Reconstruction, Endoscopic Surgery, Robotic Surgery
Peking University People's Hospital
Observational
484
Beijing
2025-01-03
Recruiting
Vitreous Zonule in Primary Angle-Closure Glaucoma
NCT07523139Primary Angle-Closure Glaucoma
Peking University People's Hospital
Observational
440
Beijing
2025-01-01
Active, closed
The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination
NCT06751251Sarcoma, Biomarkers, Progression
Peking University People's Hospital
Observational
200
Beijing
2025-01-01
Recruiting
BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
NCT06794008Systemic Lupus Erythematosus, Inflammatory Myopathy, Systemic Sclerosis (SSc), ANCA-associated Vasculitis
Peking University People's Hospital
Phase 2
50
Beijing
2024-12-26
Recruiting
Predictive Value of Myelodysplastic Syndrome Stem Cells Determined by Multiparameter Flow Cytometry
NCT06569095Myelodysplastic Syndromes
Peking University People's Hospital
Observational
163
Beijing, Wuhan, Zhengzhou
2024-12-09
Not yet open
Research on the Application of Patient Navigation-based Management Model of Patients After LEEP
NCT06695871Cervical Intraepithelial Neoplasias
Peking University People's Hospital
Not applicable
128
Beijing
2024-12-01
Recruiting
Impact of Recombinant Humanized Type III Collagen on the Immediate and Long-term Effects of Breast Tumor Surgery
NCT06725082Breast Cancer, Collagen Protein
Peking University People's Hospital
Phase 1
30
Beijing
2024-12-01
Active, closed
Treatment Duration of IPA
NCT06583512Invasive Aspergillosis, Antifungal Therapy
Peking University People's Hospital
Observational
15
Beijing
2024-12-01
Recruiting
Risk Stratification and MRD-driven Maintenance for MM After ASCT
NCT06697483Multiple Myeloma
DrugsDaratumumab·Lenalidomide
Peking University People's Hospital
Not applicable
100
Beijing, Harbin
2024-12-01
Rows per page Showing 1–100 of 158
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 158 of those studies with a site in Beijing that also match the filters currently applied.

How many clinical trials are recruiting in Beijing?

108 of the 158 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 31 have not yet opened recruitment, 15 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beijing), 158 studies
PhaseStudiesRecruitingShare
Observational563735.4%
Not applicable443027.8%
Phase 2301619%
Phase 1/2985.7%
Phase EARLY_PHASE1653.8%
Phase 1553.2%
Phase 3432.5%
Phase 2/3331.9%
Phase 4110.6%

Most active sponsors

Lead sponsors with the most studies (Beijing)
Lead sponsorStudiesRecruiting
Peking University People's Hospital158108
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.